A Phase 2 Treatment Withdrawal Clinical Trial of a Bicarbonate-Buffered, Enteric-Coated Pancreatic Enzyme Supplement for the Management of Steatorrhea in Children and Young Adults With Alagille Syndrome After Liver Transplantation
Latest Information Update: 21 Jan 2026
At a glance
- Drugs Pancrelipase (Primary)
- Indications Steatorrhoea
- Focus Therapeutic Use
- Sponsors Digestive Care
Most Recent Events
- 21 Jan 2026 New trial record